Monocytes appear to be able to differentiate into an endothelial precursor population [43], and a chimeric cell that is CD68 (+), S-100 (+), and CD14 (−) has been implicated in diseases such as scleroderma [44]. This evidence concerns the gene CD14 and scleroderma.